Hal Baseman Chief Operating Officer at Valsource Rick Bright Senior Vice President, Pandemic Prevention & Response, Health Initiative at the Rockefeller Foundation Karen Flynn President, Biologics & Chief Commercial Officer at Catalent Kenneth C. Frazier Chairman and Chief Executive Officer at Merck Sharp & Dohme Justin Hanes Lewis J. Ort Professor of Ophthalmology at John Hopkins University; and Director at the Center for Nanomedicine Jackie Hunter Board Director at BenevolentAI Maik Jornitz President and CEO at G-Con Manufacturing Maria José Alonso Professor at the University of Santiago de Compostela CIMUS Research Institute Jean-Paul Kress CEO at MorphoSys Neil Kumar Founder and CEO at BridgeBio Pharma Emmanuel Ligner President and CEO at Cytiva; Group Executive at Danaher Biotechnology Group Kiran Mazumdar-Shaw Executive Chairperson at Biocon and Biocon Biologics Rino Rappuoli Chief Scientist and Head of External R&D at GlaxoSmithKline Mike Rea Chief Executive Officer, Idea Pharma Melinda Richter Global Head of JLabs at Johnson & Johnson Innovation Gil Roth President at the Pharma & Biopharma Outsourcing Association James N. Thomas EVP, Global Head of Biotherapeutics and President of US Operations at Just - Evotec Biologics Jan van de Winkel President and CEO at Genmab Mike Vandiver Senior Vice President of Biotherapeutic Operations at Just - Evotec Biologics Emma Walmsley Chief Executive Officer at GlaxoSmithKline
